The aerosol platform promises broader protection against SARS-CoV-2, and is currently being trialed as a booster.
Biomaterial-based COVID-19 vaccine shows adaptive immunity in mice
A biomaterials platform offers a stable center within the body for antibody development against SARS-CoV-2.
Third shot of COVID-19 vaccine not justified, says research
An expert review finds that booster shots for the general population are not yet necessary since vaccine efficacy against severe COVID-19 remains high.
Fridge-free COVID-19 vaccine candidates offer hope to billions
Two vaccines in early development are stable under high temperatures and could be game changers in global vaccine equity.
Graphene adjuvant improves efficacy of dendritic cell vaccines
Dendritic cell vaccines offer a unique opportunity in biomedicine, and limitations in efficacy can now potentially be overcome using graphene oxide nanosheets.
Pfizer to seek approval for a new COVID-19 booster shot
Citing concern over vaccine efficacy against emerging variants, Pfizer seeks approval for a third booster, but many are not yet convinced it is necessary.
Improving one of medicine’s greatest inventions: Vaccines
Integrating vaccines with biomaterials could help minimize the need for refrigeration and booster shots.
What are mRNA vaccines?
With a long history of development, mRNA vaccines are finally making their debut and changing the face of the COVID-19 pandemic.
Why is there hype around the Novavax COVID-19 vaccine?
The protein-based vaccine has been highly anticipated, showing high efficacy against variants of concern.
Why are antiviral drugs for COVID-19 difficult to find?
Viruses are so varied and evolve so quickly that creating effective treatments against them becomes a daunting task.